Medical Devices

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, the team has empowered exceptional entrepreneurs through capital, expertise, and market access, focusing on large unmet patient needs in chronic diseases, particularly cardio & neurovascular disorders.

7 Gate Ventures is a venture capital firm based in Vancouver, Canada, and Silicon Valley. They invest in early-stage startups from Pre-Seed to pre-Series A, focusing on innovative technology companies. Their mission is to partner with technical founders and help them scale.

The corporate venture arm of AbbVie, investing in novel, transformational therapeutics at discovery and preclinical stages.

Adjuvant Capital is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges. It focuses on historically overlooked market segments, leveraging expertise to translate opportunities into social and financial returns. The firm's investment model is heavily influenced by global trends such as climate change and antimicrobial resistance.

Amplitude Ventures is a savvy investor and proven company builder focused on bringing exceptional healthcare innovations to market. They work with healthcare entrepreneurs to deliver life-changing therapies to patients while providing superior value to investors. Their expertise lies in precision medicine, and they have a strong track record of supporting companies from early stages to IPO.

Arboretum Ventures is a healthcare venture capital firm based in Ann Arbor, Michigan. They focus on early-stage investments in medical devices, life science tools, tech-enabled care delivery, and pharma adjacencies. Their investment strategy emphasizes under-ventured opportunities and building strong partnerships with entrepreneurs.

Axil Capital is a venture capital firm specializing in biomedical and healthcare technology investments. They focus on supporting the growth of early-stage ventures and leveraging their global network to create synergies between the Japanese and global biotech ecosystems. Their investments span the full spectrum of the life science industry, from seed to crossover rounds.

Blackbird is an Australasian investment firm that invests in ambitious companies across various technology sectors. They focus on backing founders with generational ambition, supporting them from idea stage to beyond IPO. Blackbird provides not just capital, but also a strong community and resources.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science with the potential for significant patient benefit, focusing on areas like immunology, regenerative medicine, and digital health. The fund provides financial support and strategic guidance to portfolio companies.

Boomerang Ventures is a combination venture studio and fund focused on connected health technologies. They partner with founders and investors to disrupt healthcare. They invest in and build early-growth stage companies innovating healthcare.

Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investments. They leverage the partners' deep operating experience and successful investment background, primarily investing in technology and life sciences sectors.

Correlation Ventures is an early-stage venture capital firm with a data-driven approach. They focus on making rapid investment decisions and building strong relationships with portfolio companies to support their growth. Their efficient process and broad network help startups find the right investors and partners.